Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

Identification of CD8+ cytotoxic T lymphocyte epitopes from porcine reproductive and respiratory syndrome virus matrix protein in BALB/c mice

Authors: Weijun Zhang, Yan Lin, Yu Bai, Tiegang Tong, Qun Wang, Nihong Liu, Guangliang Liu, Yihong Xiao, Tao Yang, Zhigao Bu, Guangzhi Tong, Donglai Wu

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Twenty-seven nanopeptides derived from the matrix (M) protein of porcine reproductive and respiratory syndrome virus (PRRSV) were screened for their ability to elicit a recall interferon-γ (IFN-γ) response from the splenocytes of BALB/c mice following DNA vaccination and a booster vaccination with recombinant vaccinia virus rWR-PRRSV-M. We identified two peptides (amino acid residues K93FITSRCRL and F57GYMTFVHF) as CD8+ cytotoxic T lymphocyte (CTL) epitopes. These peptides elicited significant numbers of IFN-γ secreting cells, compared with other M nonapeptides and one irrelevant nonapeptide. Bioinformatics analysis showed that the former is an H-2K d -restricted CTL epitope, and the latter is an H-2D d -restricted CTL epitope. Multiple amino acid sequence alignment among different PRRSV M sequences submitted to GenBank indicated that these two CTL epitopes are strongly conserved, and they should therefore be considered for further research on the mechanisms of cellular immune responses to PRRSV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cho JG, Dee SA: Porcine reproductive and respiratory syndrome virus. Theriogenology 2006, 66: 655-662. 10.1016/j.theriogenology.2006.04.024CrossRefPubMed Cho JG, Dee SA: Porcine reproductive and respiratory syndrome virus. Theriogenology 2006, 66: 655-662. 10.1016/j.theriogenology.2006.04.024CrossRefPubMed
2.
go back to reference Dea S, Gagnon CA, Mardassi H, Pirzadeh B, Rogan D: Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Arch Virol 2000, 145: 659-688. 10.1007/s007050050662CrossRefPubMed Dea S, Gagnon CA, Mardassi H, Pirzadeh B, Rogan D: Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Arch Virol 2000, 145: 659-688. 10.1007/s007050050662CrossRefPubMed
3.
go back to reference Vashisht K, Goldberg TL, Husmann RJ, Schnitzlein W, Zuckermann FA: Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virus. Vaccine 2008, 26: 4747-4753. 10.1016/j.vaccine.2008.06.047CrossRefPubMed Vashisht K, Goldberg TL, Husmann RJ, Schnitzlein W, Zuckermann FA: Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virus. Vaccine 2008, 26: 4747-4753. 10.1016/j.vaccine.2008.06.047CrossRefPubMed
4.
go back to reference Bautista EM, Suarez P, Molitor TW: T cell responses to the structural polypeptides of porcine reproductive and respiratory syndrome virus. Arch Virol 1999, 144: 117-134. 10.1007/s007050050489CrossRefPubMed Bautista EM, Suarez P, Molitor TW: T cell responses to the structural polypeptides of porcine reproductive and respiratory syndrome virus. Arch Virol 1999, 144: 117-134. 10.1007/s007050050489CrossRefPubMed
5.
go back to reference Nielsen HS, Oleksiewicz MB, Forsberg R, Stadejek T, Botner A: T Storgaard, Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J Gen Virol 2001, 82: 1263-1272.CrossRefPubMed Nielsen HS, Oleksiewicz MB, Forsberg R, Stadejek T, Botner A: T Storgaard, Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J Gen Virol 2001, 82: 1263-1272.CrossRefPubMed
6.
go back to reference Murtaugh MP, Xiao Z, Zuckermann F: Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol 2002, 15: 533-547. 10.1089/088282402320914485CrossRefPubMed Murtaugh MP, Xiao Z, Zuckermann F: Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol 2002, 15: 533-547. 10.1089/088282402320914485CrossRefPubMed
7.
go back to reference Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995, 13: 29-60. 10.1146/annurev.iy.13.040195.000333CrossRefPubMed Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995, 13: 29-60. 10.1146/annurev.iy.13.040195.000333CrossRefPubMed
8.
go back to reference Yewdell JW, Haeryfar SM: Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu Rev Immunol 2005, 23: 651-682. 10.1146/annurev.immunol.23.021704.115702CrossRefPubMed Yewdell JW, Haeryfar SM: Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu Rev Immunol 2005, 23: 651-682. 10.1146/annurev.immunol.23.021704.115702CrossRefPubMed
9.
go back to reference Rutigliano JA, Rock MT, Johnson AK, Crowe JE, Graham BS: Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 2005, 337: 335-343. 10.1016/j.virol.2005.04.032CrossRefPubMed Rutigliano JA, Rock MT, Johnson AK, Crowe JE, Graham BS: Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 2005, 337: 335-343. 10.1016/j.virol.2005.04.032CrossRefPubMed
10.
go back to reference Tourdot S, Herath S, Gould KG: Characterization of a new H-2D(k)-restricted epitope prominent in primary influenza A virus infection. J Gen Virol 2001, 82: 1749-1755.CrossRefPubMed Tourdot S, Herath S, Gould KG: Characterization of a new H-2D(k)-restricted epitope prominent in primary influenza A virus infection. J Gen Virol 2001, 82: 1749-1755.CrossRefPubMed
11.
go back to reference Barfoed AM, Rodriguez F, Therrien D, Borrego B, Sobrino F, Kamstrup S: DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice. Antiviral Res 2006, 72: 178-189. 10.1016/j.antiviral.2006.07.002CrossRefPubMed Barfoed AM, Rodriguez F, Therrien D, Borrego B, Sobrino F, Kamstrup S: DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice. Antiviral Res 2006, 72: 178-189. 10.1016/j.antiviral.2006.07.002CrossRefPubMed
12.
go back to reference Shen G, Jin N, Ma M, Jin K, Zheng M, Zhuang T, Lu H, Zhu G, Jin H, Jin M, Huo X, Qin X, Yin R, Li C, Li H, Li Y, Han Z, Chen Y: Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Vaccine 2007, 25: 4193-4202. 10.1016/j.vaccine.2007.03.010CrossRefPubMed Shen G, Jin N, Ma M, Jin K, Zheng M, Zhuang T, Lu H, Zhu G, Jin H, Jin M, Huo X, Qin X, Yin R, Li C, Li H, Li Y, Han Z, Chen Y: Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Vaccine 2007, 25: 4193-4202. 10.1016/j.vaccine.2007.03.010CrossRefPubMed
13.
go back to reference Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50: 213-219. 10.1007/s002510050595CrossRefPubMed Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50: 213-219. 10.1007/s002510050595CrossRefPubMed
14.
go back to reference Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994, 152: 163-175.PubMed Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994, 152: 163-175.PubMed
15.
go back to reference Zhang GL, Srinivasan KN, Veeramani A, August JT, Brusic V: PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse. Nucleic Acids Res 2005, 33: W180-183. 10.1093/nar/gki479PubMedCentralCrossRefPubMed Zhang GL, Srinivasan KN, Veeramani A, August JT, Brusic V: PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse. Nucleic Acids Res 2005, 33: W180-183. 10.1093/nar/gki479PubMedCentralCrossRefPubMed
16.
go back to reference Barfoed AM, Blixenkrone-Moller M, Jensen MH, Botner A, Kamstrup S: DNA vaccination of pigs with open reading frame1–7of PRRS virus. Vaccine 2004, 22: 3628-3641. 10.1016/j.vaccine.2004.03.028CrossRefPubMed Barfoed AM, Blixenkrone-Moller M, Jensen MH, Botner A, Kamstrup S: DNA vaccination of pigs with open reading frame1–7of PRRS virus. Vaccine 2004, 22: 3628-3641. 10.1016/j.vaccine.2004.03.028CrossRefPubMed
17.
go back to reference Boots AM, Kusters JG, van Noort JM, Zwaagstra KA, Rijke E, van der Zeijst BA, Hensen EJ: Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 1991, 74: 8-13.PubMedCentralPubMed Boots AM, Kusters JG, van Noort JM, Zwaagstra KA, Rijke E, van der Zeijst BA, Hensen EJ: Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 1991, 74: 8-13.PubMedCentralPubMed
18.
go back to reference Wee EG, Patel S, McMichael AJ, Hanke T: A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques. J Gen Virol 2002, 83: 75-80.CrossRefPubMed Wee EG, Patel S, McMichael AJ, Hanke T: A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques. J Gen Virol 2002, 83: 75-80.CrossRefPubMed
19.
go back to reference McConkey SJ, Reece WH, Moorthy VS, Webster D, Dunachie S, Butcher G, Vuola JM, Blanchard TJ, Gothard P, Watkins K, Hannan CM, Everaere S, Brown K, Kester KE, Cummings J, Williams J, Heppner DG, Pathan A, Flanagan K, Arulanantham N, Roberts MT, Roy M, Smith GL, Schneider J, Peto T, Sinden RE, Gilbert SC, Hill AV: Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 2003, 9: 729-735. 10.1038/nm881CrossRefPubMed McConkey SJ, Reece WH, Moorthy VS, Webster D, Dunachie S, Butcher G, Vuola JM, Blanchard TJ, Gothard P, Watkins K, Hannan CM, Everaere S, Brown K, Kester KE, Cummings J, Williams J, Heppner DG, Pathan A, Flanagan K, Arulanantham N, Roberts MT, Roy M, Smith GL, Schneider J, Peto T, Sinden RE, Gilbert SC, Hill AV: Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 2003, 9: 729-735. 10.1038/nm881CrossRefPubMed
Metadata
Title
Identification of CD8+ cytotoxic T lymphocyte epitopes from porcine reproductive and respiratory syndrome virus matrix protein in BALB/c mice
Authors
Weijun Zhang
Yan Lin
Yu Bai
Tiegang Tong
Qun Wang
Nihong Liu
Guangliang Liu
Yihong Xiao
Tao Yang
Zhigao Bu
Guangzhi Tong
Donglai Wu
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-263

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine